US Broker Ratings

Twist Bioscience Corporation (TWST) Investor Outlook: Navigating Growth Potential Amidst Challenging Metrics

Twist Bioscience Corporation (NASDAQ: TWST), a prominent player in the Healthcare sector, particularly within the Diagnostics & Research industry, continues to captivate investors with its innovative synthetic DNA-based products. Headquartered..

SS Innovations International (SSII) Stock Analysis: Navigating the Highs and Lows of a Promising Medical Device Innovator

SS Innovations International, Inc. (SSII) is a burgeoning player in the healthcare sector, particularly within the medical devices industry. Headquartered in Gurugram, India, the company is carving out a niche..

PACS Group, Inc. (PACS) Stock Analysis: A Healthcare Gem with 241% Potential Upside

For investors with an eye for opportunity in the healthcare sector, PACS Group, Inc. (PACS) presents an intriguing proposition. Operating within the medical care facilities industry, PACS Group is headquartered..

Clover Health Investments (CLOV): Investor Outlook with a 57% Potential Upside

Clover Health Investments, Corp (NASDAQ: CLOV) is capturing investor attention with a substantial potential upside of 57.30%, according to recent analyst ratings. Positioned within the healthcare sector, specifically focusing on..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Exploring a 53.64% Upside Potential

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a biotech entity focused on pioneering therapeutics in the realm of cellular metabolism, is capturing investor attention with its promising portfolio and substantial upside potential...

Evotec SE (EVO) Stock Analysis: Exploring the 59.77% Potential Upside for Innovative Drug Discovery

Evotec SE (EVO) is at the forefront of the drug discovery and development sector, serving as a key partner to the pharmaceutical and biotechnology industries worldwide. Headquartered in Hamburg, Germany,..

Merus N.V. (MRUS) Stock Analysis: Exploring 63.66% Potential Upside and Strong Buy Ratings

Merus N.V. (NASDAQ: MRUS), a Netherlands-based biotechnology enterprise, has been capturing investor attention with an impressive potential upside of 63.66% according to analyst forecasts. This clinical-stage immuno-oncology company, headquartered in..

GeneDx Holdings Corp. (WGS) Stock Analysis: Unveiling a Potential 31% Upside in Genomic Diagnostics

GeneDx Holdings Corp. (NASDAQ: WGS) stands out in the healthcare sector as a pioneering entity in the Diagnostics & Research industry. Based in Stamford, Connecticut, the company specializes in providing..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: A Biotech Powerhouse with a 133% Upside Potential

Apogee Therapeutics, Inc. (NASDAQ: APGE) has emerged as a noteworthy contender in the biotechnology sector, with its innovative approach to treating inflammatory and immunology disorders. Despite a challenging market environment,..

HUTCHMED (HCM) Stock Analysis: Exploring a 60% Upside in the Healthcare Sector

HUTCHMED (China) Limited (HCM) is carving out a prominent niche in the healthcare sector, focusing on pioneering therapies for cancer and immunological diseases. With a market capitalization of $2.73 billion,..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Unearthing a 23% Upside Potential in Biotech

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a compelling player in the biotechnology sector, is capturing the attention of investors with its robust pipeline of peptide therapeutics and promising market performance. Headquartered..

Phreesia, Inc. (PHR) Stock Analysis: 14.81% Potential Upside Fuels Investor Interest

Phreesia, Inc. (PHR), a key player in the Health Information Services industry, is making waves in the healthcare sector with its innovative software and payment solutions. With a market capitalization..

Acadia Healthcare (ACHC) Stock Analysis: A 94.89% Potential Upside Beckons Investors

In the vast landscape of healthcare investments, Acadia Healthcare Company, Inc. (NASDAQ: ACHC) presents a compelling case for investor attention. With a market capitalization of $2.03 billion, this Franklin, Tennessee-based..

Brookdale Senior Living Inc. (BKD) Investor Outlook: Navigating a 17% Potential Upside Amidst Operational Challenges

Brookdale Senior Living Inc. (NYSE: BKD) presents a compelling case for investors seeking opportunities in the healthcare sector, particularly within medical care facilities. With its headquarters in Brentwood, Tennessee, Brookdale..

Surgery Partners, Inc. (SGRY) Stock Analysis: Uncovering a 34% Potential Upside in Healthcare Sector

Surgery Partners, Inc. (SGRY) stands as a noteworthy contender in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Brentwood, Tennessee, this company has carved out a..

ICU Medical, Inc. (ICUI) Stock Analysis: Exploring a 36.66% Potential Upside

ICU Medical, Inc. (ICUI), a key player in the healthcare sector, operates in the niche industry of medical instruments and supplies. With a market capitalization of $3.35 billion, ICU Medical..

National HealthCare Corporation (NHC) Stock Analysis: Strong Revenue Growth and Reliable Dividends for Healthcare Investors

National HealthCare Corporation (NYSE: NHC) presents a compelling case for investors interested in the healthcare sector. With a robust market capitalization of $1.62 billion, NHC operates in the medical care..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Eyeing a 75% Upside with Strong Buy Ratings

Investors with a focus on biopharmaceutical innovation might find Xenon Pharmaceuticals Inc. (NASDAQ: XENE) a compelling addition to their portfolios. Specializing in neuroscience-focused therapeutics, Xenon is at the forefront of..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Exploring a Potential 71.65% Upside

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a promising player in the biotechnology sector, has been capturing investor attention with its innovative approach to eye care treatment. Headquartered in Irvine, California, Tarsus..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Unpacking a 142% Potential Upside

Beam Therapeutics Inc. (NASDAQ: BEAM), a pioneering entity in the biotechnology sector, is drawing significant attention from investors due to its impressive potential upside of 142.52%, as indicated by recent..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds